company background image
1777 logo

SYN-TECH Chem. & Pharm TPEX:1777 Stock Report

Last Price

NT$90.30

Market Cap

NT$4.0b

7D

0.1%

1Y

3.0%

Updated

13 Jun, 2024

Data

Company Financials

SYN-TECH Chem. & Pharm. Co., Ltd.

TPEX:1777 Stock Report

Market Cap: NT$4.0b

1777 Stock Overview

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan and internationally.

1777 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

SYN-TECH Chem. & Pharm. Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SYN-TECH Chem. & Pharm
Historical stock prices
Current Share PriceNT$90.30
52 Week HighNT$91.40
52 Week LowNT$81.70
Beta0.13
1 Month Change1.92%
3 Month Change9.06%
1 Year Change2.96%
3 Year Change13.73%
5 Year Change14.74%
Change since IPO347.62%

Recent News & Updates

Recent updates

SYN-TECH Chem. & Pharm (GTSM:1777) Could Easily Take On More Debt

Mar 19
SYN-TECH Chem. & Pharm (GTSM:1777) Could Easily Take On More Debt

Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield

Feb 26
Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield

Declining Stock and Decent Financials: Is The Market Wrong About SYN-TECH Chem. & Pharm. Co., Ltd. (GTSM:1777)?

Feb 05
Declining Stock and Decent Financials: Is The Market Wrong About SYN-TECH Chem. & Pharm. Co., Ltd. (GTSM:1777)?

SYN-TECH Chem. & Pharm's (GTSM:1777) Shareholders Are Down 11% On Their Shares

Jan 10
SYN-TECH Chem. & Pharm's (GTSM:1777) Shareholders Are Down 11% On Their Shares

SYN-TECH Chem. & Pharm (GTSM:1777) Seems To Use Debt Rather Sparingly

Dec 19
SYN-TECH Chem. & Pharm (GTSM:1777) Seems To Use Debt Rather Sparingly

Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield

Nov 28
Here's What You Should Know About SYN-TECH Chem. & Pharm. Co., Ltd.'s (GTSM:1777) 4.6% Dividend Yield

Shareholder Returns

1777TW PharmaceuticalsTW Market
7D0.1%0.1%2.5%
1Y3.0%6.5%26.3%

Return vs Industry: 1777 underperformed the TW Pharmaceuticals industry which returned 6.5% over the past year.

Return vs Market: 1777 underperformed the TW Market which returned 26.3% over the past year.

Price Volatility

Is 1777's price volatile compared to industry and market?
1777 volatility
1777 Average Weekly Movement1.6%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 1777 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1777's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982220n/awww.syn-tech.com.tw

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, dipeptidyl peptidase 4 inhibitor/antidiabetic, antihyertensive, a- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, hvponatremia, antiglaucoma agent, pharmaceutic aid / lubricant, sedative, and analgesic.

SYN-TECH Chem. & Pharm. Co., Ltd. Fundamentals Summary

How do SYN-TECH Chem. & Pharm's earnings and revenue compare to its market cap?
1777 fundamental statistics
Market capNT$4.03b
Earnings (TTM)NT$272.87m
Revenue (TTM)NT$1.12b

14.8x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1777 income statement (TTM)
RevenueNT$1.12b
Cost of RevenueNT$713.53m
Gross ProfitNT$403.65m
Other ExpensesNT$130.78m
EarningsNT$272.87m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)6.12
Gross Margin36.13%
Net Profit Margin24.43%
Debt/Equity Ratio7.1%

How did 1777 perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

57%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.